Retour
Fourchette du Jour
4,17 €
4,25 €
Fourchette 52 Semaines
3,78 €
5,00 €
Volume
1 200
Moyenne 50J / 200J
4,33 €
/
4,45 €
Clôture Précédente
4,17 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,1 | 0,3 |
| P/B | 0,0 | 3,0 |
| ROE % | -9,2 | 3,7 |
| Net Margin % | -14,4 | 3,8 |
| Rev Growth 5Y % | 2,4 | 10,0 |
| D/E | 0,8 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
29,31 €
26,31 € – 32,48 €
|
40,17B | 1 |
| FY2029 |
16,12 €
14,47 € – 17,87 €
|
38,39B | 1 |
| FY2028 |
14,49 €
13,01 € – 16,06 €
|
38,45B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-28 | -1,07 € | 0,00 € | +100,2% |
| 2025-10-30 | 0,14 € | 0,13 € | -9,2% |
| 2025-07-28 | 0,03 € | -0,03 € | -202,3% |
| 2025-05-13 | -0,36 € | -0,24 € | +34,2% |
| 2025-01-31 | 0,07 € | 0,01 € | -91,6% |
| 2024-10-30 | 0,10 € | -0,05 € | -152,4% |
| 2024-07-30 | 0,05 € | 0,01 € | -81,0% |
| 2024-05-10 | 0,11 € | 0,02 € | -83,5% |
Dividend History
Yield
0,03%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Jun 01, 2026 | 0,07 € | 3,24% |
| Sep 30, 2025 | Dec 05, 2025 | 0,07 € | 3,16% |
| Mar 31, 2025 | Jun 26, 2025 | 0,07 € | 3,00% |
| Sep 30, 2024 | Dec 06, 2024 | 0,07 € | 2,90% |
| Mar 28, 2024 | Jun 27, 2024 | 0,07 € | 1,47% |
| Sep 28, 2023 | Dec 08, 2023 | 0,07 € | 1,41% |
| Mar 30, 2023 | Jun 22, 2023 | 0,08 € | 1,39% |
| Sep 29, 2022 | Dec 09, 2022 | 0,07 € | 0,87% |
| Mar 30, 2022 | Jun 23, 2022 | 0,10 € | 1,05% |
| Sep 29, 2021 | Dec 10, 2021 | 0,09 € | 0,56% |
| Mar 30, 2021 | Jun 24, 2021 | 0,07 € | 0,33% |
| Sep 29, 2020 | Dec 10, 2020 | 0,17 € | 0,24% |
| Mar 30, 2020 | Jun 25, 2020 | 0,04 € | 0,22% |
| Sep 27, 2019 | Dec 10, 2019 | 0,03 € | 0,22% |
| Mar 27, 2019 | Jun 28, 2019 | 0,04 € | 0,20% |
| Sep 26, 2018 | Dec 10, 2018 | 0,03 € | 0,18% |
| Mar 28, 2018 | Jun 28, 2018 | 0,03 € | 0,18% |
| Sep 27, 2017 | Dec 08, 2017 | 0,03 € | 0,16% |
| Mar 29, 2017 | Jun 29, 2017 | 0,03 € | 0,08% |
Points Clés
Revenue grew 2,39% annually over 5 years — modest growth
Earnings declined -186,42% over the past year
Negative free cash flow of -15,37B
PEG of 0,10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 25,25%
Croissance
Revenue Growth (5Y)
2,39%
Revenue (1Y)-22,86%
Earnings (1Y)-186,42%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-9,22%
ROIC-5,86%
Net Margin-14,39%
Op. Margin-20,11%
Sécurité
Debt / Equity
0,81
Current Ratio1,16
Interest Coverage-42,90
Valorisation
P/E Ratio
-0,11
Forward P/EN/A
P/B Ratio0,01
EV/EBITDAN/A
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -22,86% | Revenue Growth (3Y) | -1,87% |
| Earnings Growth (1Y) | -186,42% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33,07B | Net Income (TTM) | -4,76B |
| ROE | -9,22% | ROA | -4,54% |
| Gross Margin | 65,73% | Operating Margin | -20,11% |
| Net Margin | -14,39% | Free Cash Flow (TTM) | -15,37B |
| ROIC | -5,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,81 | Current Ratio | 1,16 |
| Interest Coverage | -42,90 | ||
| Dividends | |||
| Dividend Yield | 0,03% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,11 | Forward P/E | N/A |
| P/B Ratio | 0,01 | P/S Ratio | 0,02 |
| PEG Ratio | 0,10 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -3022,38% | ||
| Market Cap | 508,67M | Enterprise Value | 25,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33,07B | 42,87B | 34,34B | 51,08B | 30,09B |
| Net Income | -4,76B | 5,51B | 3,77B | 14,51B | 6,89B |
| EPS (Diluted) | -38,43 | 43,92 | 30,22 | 116,79 | 55,52 |
| Gross Profit | 21,74B | 31,25B | 25,46B | 40,62B | 22,27B |
| Operating Income | -6,65B | 7,53B | 4,98B | 19,93B | 8,27B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 104,86B | 102,23B | 94,94B | 97,13B | 73,78B |
| Total Liabilities | 57,42B | 45,75B | 42,53B | 46,05B | 35,23B |
| Shareholders' Equity | 47,04B | 56,18B | 52,16B | 50,88B | 38,38B |
| Total Debt | 38,11B | 23,30B | 22,80B | 18,10B | 18,10B |
| Cash & Equivalents | 13,20B | 18,76B | 13,28B | 30,73B | 26,26B |
| Current Assets | 51,06B | 57,58B | 47,80B | 62,19B | 48,55B |
| Current Liabilities | 43,99B | 30,14B | 35,76B | 42,05B | 29,03B |